Monday / May 19. 2025
menu-logo menu-logo
brand-logo
Subscribe
Subscribe
Monday / May 19. 2025
  • Read
    • Daily News
      • Financial
      • Insights
      • U.S.
      • International
    • Digital Issue
    • Executive Announcements
    • Cover Stories
    • Feature Articles
      • Exclusive Interviews
    • International Focus
    • Company Spotlights
    • Forward Thinking
    • Legal Briefs
    • Insights from the Outside
    • For You | For Your Field
    • Working Smart
  • Listen & Watch
    • Direct Approach Podcast
    • SHIFT podcast
    • The DSN Podcast
  • Attend
    • DSU Europe 2025
    • DSU Fall 2025
  • Achieve
    • Global 100 List
    • Bravo Awards
    • Best Places to Work
    • Legends
  • Research
    • Stock Watch
    • The DSN Guide
    • Supplier Directory
    • Stock Ticker
    • Resources
  • Engage
    • Supporter Program
    • VIP Text Alerts
  • About
    • About DSN
    • Subscribe
    • Advertise
    • Connect
  • Search
Subscribe

Heightened Scrutiny of Product Claims Amid The COVID-19 Pandemic

BY R. Todd Eliason | April 15, 2020 | read / Feature Articles

As the COVID-19 pandemic continues to wreak havoc in the medical and business community, direct sales companies face the added pressure of ensuring that their independent sales representatives are not seeking to boost sales by making unauthorized health claims related to the coronavirus.

Statements that imply or expressly claim that a product can treat or alleviate COVID-19 symptoms will almost certainly invite immediate regulatory scrutiny.

On April 7, the Direct Selling Association (DSA) and Direct Selling Self-Regulatory Council (DSSRC) issued a joint press release cautioning direct selling companies and their independent salesforces from making claims suggesting that products:

  • Treat or alleviate the symptoms of COVID-19;
  • Cure, treat or alleviate symptoms of COVID-19;
  • Boost or improve immune function that can prevent COVID-19; and/or
  • Eliminate or remove viruses.

The press release stated that DSSRC has already contacted several direct selling companies regarding COVID-19 claims. On April 10, the FTC issued an alert warning consumers about COVID-19 scams that “take advantage of anxieties related to the Coronavirus.”

The direct selling industry experienced a rough end to 2019. FTC regulatory enforcement actions were filed against two prominent companies and there were alarming public statements by FTC’s Andrew Smith suggesting that the FTC is applying a new definition of pyramid scheme in evaluating MLM compensation structures.

Heightened Scrutiny on Health Claims

With the FTC’s heightened scrutiny of the direct selling channel, direct sellers can ill afford the reputational damage (and certain adverse regulatory enforcement action) that would result if a company (or its independent salespeople) seeks to capitalize on the current pandemic by making unsubstantiated health claims. It is not hard to imagine how Mr. Smith and his FTC cohorts would prioritize and aggressively prosecute a direct selling company seeking to capitalize on the COVID-19 crisis by making improper health claims.

“Statements that imply or expressly claim that a product can treat or alleviate COVID-19 symptoms will almost certainly invite immediate regulatory scrutiny.”
– Brent Kugler, Partner Scheef & Stone, LLP

The Centers for Disease Control and Prevention and the Food and Drug Administration have both stated that there are no approved vaccines, drugs or investigational products currently available to treat or prevent COVID-19. Accordingly, improper health claims related to COVID-19 are certain to be highly prioritized by both the FTC, FDA and state regulatory agencies.  No direct selling company possesses reliable scientific substantiation to support a claim that a product can treat or mitigate COVID-19 symptoms or prevent exposure to the virus.

Review Compliance with FTC Standards

The regulatory parameters for compliant product claims are well known. Companies must ensure that product claims comply with, among other things, the FTC Policy Statement Regarding Advertising Substantiation, the FTC Guide Concerning the Use of Endorsements and Testimonials in Advertising, the FTC’s revised Dot.com Disclosure Guide and applicable FDA regulations regarding reliable scientific substantiation for product efficacy claims. These standards apply to consumable products as well as cleaning materials and personal protective equipment such as masks and gloves.

Just as critically, companies must monitor the sales activities of their independent sales forces. In his statements to the DSA in October 2019, FTC’s Smith made it clear that the FTC intends to hold companies accountable for the claims and representations made by its independent sales representatives. With revenues declining, some companies may be inclined to “look the other way” rather than confront and deal with a distributor who is making illegal health claims to boost product sales. Companies must resist this temptation, both for their own survival and also to prevent massive damage to the image and reputation of the direct selling channel at this critical time.


Brent Kugler is a partner with Scheef & Stone in Dallas, Texas. Brent is a prominent attorney is a direct selling industry with extensive experience in representing direct sales, multilevel and network marketing companies in lawsuits, arbitrations regularities matter across the untied states.

Posted in Feature Articles and tagged Brent Kugler Scheef & Stone, Coronavirus, COVID-19 Effect on Direct Selling, Direct Selling, Direct Selling Association, Direct Selling FTC Compliance, Direct Selling Self-Regulatory Council (DSSRC), MLM Compliance, network marketing.
Related Articles
Jim Northrop | More than a Mentor May 17, 2025

Jim Northrop | More than a Mentor

Read more
The Asian Pacific Advantage May 11, 2025

The Asian Pacific Advantage

Read more
Ørjan & Hilde Sæle | 20 Years of Visionary Leadership May 06, 2025

Ørjan & Hilde Sæle | 20 Years of Visionary Leadership

Read more
brand-logo
The News You Need.
The Name You Trust.
Subscribe

Breaking global news, emerging trends and powerful stories conveniently curated to help direct selling executives stay informed, engaged and a step ahead.

  • Read
  • Listen & Watch
  • Attend
  • Achieve
  • Research
  • About
  • Connect
5717 Legacy Drive
Suite 250
Plano, Texas 75024
info@directsellingnews.com
Copyright 2025 Direct Selling News | All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Subscribe
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT